Atlas Trials

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

Clinical trial NCT01958918 · COMPLETED

Trial details

NCT number
NCT01958918
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neovascular Age-related Macular Degeneration
Start date
2013-10-23
Primary completion
2016-11-22
Enrollment
712

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.